Accordingly, we identified the interaction between EZH2 and TFIIIC102 in another breast cancer cell line SUM159 (Figure 1c), suggesting that the interaction between EZH2 and TFIIIC102 occurs widely in breast cancer cells. Here, EZH2 is linked to breast carcinoma.